Australia markets closed

Concord Medical Services Holdings Limited (CCM)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
1.95000.0000 (0.00%)
At close: 02:52PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 84.66M
Enterprise value 467.61M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.18
Price/book (mrq)3.00
Enterprise value/revenue 0.96
Enterprise value/EBITDA -1.33

Trading information

Stock price history

Beta (5Y monthly) -0.11
52-week change 3-25.86%
S&P500 52-week change 3-4.45%
52-week high 33.4000
52-week low 31.1500
50-day moving average 31.8840
200-day moving average 31.9396

Share statistics

Avg vol (3-month) 31.62k
Avg vol (10-day) 31.05k
Shares outstanding 543.42M
Implied shares outstanding 6N/A
Float 813.3M
% held by insiders 118.00%
% held by institutions 10.52%
Shares short (28 July 2022) 48.65k
Short ratio (28 July 2022) 48.55
Short % of float (28 July 2022) 4N/A
Short % of shares outstanding (28 July 2022) 40.02%
Shares short (prior month 29 June 2022) 49.23k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 328 Jan 2016
Ex-dividend date 422 Dec 2015
Last split factor 211384:10000
Last split date 315 Jan 2014

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Dec 2021


Profit margin -55.89%
Operating margin (ttm)-94.38%

Management effectiveness

Return on assets (ttm)-4.95%
Return on equity (ttm)-20.32%

Income statement

Revenue (ttm)485.63M
Revenue per share (ttm)11.12
Quarterly revenue growth (yoy)109.10%
Gross profit (ttm)-56.9M
EBITDA -363.86M
Net income avi to common (ttm)-820.62M
Diluted EPS (ttm)-2.8030
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)157.39M
Total cash per share (mrq)3.62
Total debt (mrq)2.73B
Total debt/equity (mrq)99.60
Current ratio (mrq)0.73
Book value per share (mrq)-31.56

Cash flow statement

Operating cash flow (ttm)-359.31M
Levered free cash flow (ttm)-944.35M